Peter Tanuseputro retweetledi

Our @LancetLongevity study finds that #Statin therapy is beneficial for #hypercholesterolemic patients with chronic #kidney disease aged 75+ against #CVD and all-cause #mortality, without posing an increased risk of major adverse events.
thelancet.com/journals/lanhl…
English


















